A study highlighting this was performed approximately one decade ago. The study found a link between IBS sufferers and clinical endocannabinoid deficiency, which relates back to the fact that the system directly impacts intestinal motility and function. When CBD was used to activate and regulate the endocannabinoid system, sufferers of IBS saw significant symptom improvement. (42)
As mentioned in previous conditions, these treatments are often associated with devastating side effects, ranging from mild mood changes, sleeping problems and/or appetite changes to depression, dependance and more. In many cases, as patients become acclimated to specific doses, they are increased, leading to a higher potential for negative effects.